Home » Pharmaceutical » Pharmaceutical Contract Development and Manufacturing Market Size, Share, Analysis Report
The Pharmaceutical Contract Development and Manufacturing Market is expected to be around US$ 290 Billion by 2028 at a CAGR of 7% in the given forecast period.
The expansion of the pharmaceutical contract development and manufacturing market is propelled by the surge in the demand for medicines across the world. The high incidence of diseases and the requirement of a longer lifespan escalated the demand for medicines pushing the pharmaceutical companies to improve the production of current drugs and increase the investment in their R&D to promote the development of new drugs. This compels the pharmaceutical companies to collaborate with contract manufacturing organizations (CMOs) as a way to decrease operational costs, thereby, rising the demand in pharmaceutical contract development and manufacturing market. Furthermore, the increasing in investments in advanced manufacturing technologies by contract development and manufacturing organizations is also a key factor to accelerate the market growth.
The global Pharmaceutical Contract Development and Manufacturing market is segregated on the basis of Service as Pharmaceutical Manufacturing Services, Drug Development Services and Biologics Manufacturing Services. Based on End User the global Pharmaceutical Contract Development and Manufacturing market is segmented in Big Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies and Other End Users.
The global Pharmaceutical Contract Development and Manufacturing market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Pharmaceutical Contract Development and Manufacturing market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
AbbVie, Inc., Aenova Group GmbH, Almac Group, AMRI Global, C.H. Boehringer Sohn AG & Ko. KG, Cambrex Corporation, Catalent, Inc., Danaher Corporation, Delwis Healthcare Pvt Ltd., Evonik Industries AG, Famar Health Care Services, Fareva, Jubilant Life Sciences Limited, Lonza Group AG, Pfizer Inc., and others are among the major players in the global Pharmaceutical Contract Development and Manufacturing market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
Pharmaceutical Contract Development and Manufacturing Market has been segmented as below:
Pharmaceutical Contract Development and Manufacturing Market, By Service
Pharmaceutical Contract Development and Manufacturing Market, By End User
Pharmaceutical Contract Development and Manufacturing Market, By Region
Pharmaceutical Contract Development and Manufacturing Market, By Company
The report covers:
Report Scope:
The global Pharmaceutical Contract Development and Manufacturing market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Pharmaceutical Contract Development and Manufacturing market share. Major industry players with significant revenue share include AbbVie, Inc., Aenova Group GmbH, Almac Group, AMRI Global, C.H. Boehringer Sohn AG & Ko. KG, Cambrex Corporation, Catalent, Inc., Danaher Corporation, Delwis Healthcare Pvt Ltd., Evonik Industries AG, Famar Health Care Services, Fareva, Jubilant Life Sciences Limited, Lonza Group AG, Pfizer Inc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Human Insulin Drugs & Delivery Devices Market
Immunochemistry Reagents Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter’s Five Force Analysis
5. Pharmaceutical Contract Development and Manufacturing Market, By Service
5.1. Introduction
5.2. Pharmaceutical Manufacturing Services
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Drug Development Services
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.4. Biologics Manufacturing Services
5.4.1. Market Overview
5.4.2. Market Size and Forecast
6. Pharmaceutical Contract Development and Manufacturing Market, By End User
6.1. Introduction
6.2. Big Pharmaceutical Companies
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Small & Medium-Sized Pharmaceutical Companies
6.3.1. Market Overview
6.3.2. Market Size and Forecast
6.4. Generic Pharmaceutical Companies
6.4.1. Market Overview
6.4.2. Market Size and Forecast
6.5. Other End Users
6.5.1. Market Overview
6.5.2. Market Size and Forecast
7. Pharmaceutical Contract Development and Manufacturing Market, By Geography
7.1. Introduction
7.2. North America
7.2.1. North America Pharmaceutical Contract Development and Manufacturing, By Service
7.2.2. North America Pharmaceutical Contract Development and Manufacturing, By End User
7.3. Europe
7.3.1. Europe Pharmaceutical Contract Development and Manufacturing, By Service
7.3.2. Europe Pharmaceutical Contract Development and Manufacturing, By End User
7.4. Asia-Pacific
7.4.1. Asia-Pacific Pharmaceutical Contract Development and Manufacturing, By Service
7.4.2. Asia-Pacific Pharmaceutical Contract Development and Manufacturing, By End User
7.5. Rest of the World
7.5.1. Rest of the World Pharmaceutical Contract Development and Manufacturing, By Service
7.5.2. Rest of the World Pharmaceutical Contract Development and Manufacturing, By End User
8. Competitive Insights
8.1. Key Insights
8.2. Company Market Share Analysis
8.3. Strategic Outlook
8.3.1. Mergers & Acquisitions
8.3.2. New Product Developments
8.3.3. Portfolio/Production Capacity Expansions
8.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5. Others
9. Company Profiles
9.1. AbbVie, Inc.
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Aenova Group GmbH
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Almac Group
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. AMRI Global
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. C.H. Boehringer Sohn AG & Ko. KG
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Cambrex Corporation
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Catalent, Inc.
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. Danaher Corporation
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
9.9. Delwis Healthcare Pvt Ltd.
9.9.1. Company Overview
9.9.2. Product/Service Landscape
9.9.3. Financial Overview
9.9.4. Recent Developments
9.10. Evonik Industries AG
9.10.1. Company Overview
9.10.2. Product/Service Landscape
9.10.3. Financial Overview
9.10.4. Recent Developments
9.11. Famar Health Care Services
9.11.1. Company Overview
9.11.2. Product/Service Landscape
9.11.3. Financial Overview
9.11.4. Recent Developments
9.12. Fareva
9.12.1. Company Overview
9.12.2. Product/Service Landscape
9.12.3. Financial Overview
9.12.4. Recent Developments
9.13. Jubilant Life Sciences Limited
9.13.1. Company Overview
9.13.2. Product/Service Landscape
9.13.3. Financial Overview
9.13.4. Recent Developments
9.14. Lonza Group AG
9.14.1. Company Overview
9.14.2. Product/Service Landscape
9.14.3. Financial Overview
9.14.4. Recent Developments
9.15. Pfizer Inc.
9.15.1. Company Overview
9.15.2. Product/Service Landscape
9.15.3. Financial Overview
9.15.4. Recent Developments
Pharmaceutical Contract Development and Manufacturing Market has been segmented as below:
Pharmaceutical Contract Development and Manufacturing Market, By Service
Pharmaceutical Contract Development and Manufacturing Market, By End User
Pharmaceutical Contract Development and Manufacturing Market, By Region
Pharmaceutical Contract Development and Manufacturing Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS